Skip to main content
MEDICOX Co., Ltd. logo

MEDICOX Co., Ltd. — Investor Relations & Filings

Ticker · 054180 ISIN · KR7054180005 KO Manufacturing
Open in API
Filings indexed 803 across all filing types
Latest filing 2022-07-14 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 054180

About MEDICOX Co., Ltd.

https://www.medicox.co.kr

MEDICOX Co., Ltd., formerly ChoongAng Ocean Co Ltd, is a company engaged in the manufacture and sale of shipbuilding materials and equipment. Its primary products are structural components for large vessels, including curved blocks, bow and stern sections, propeller bosses, and engine room parts. In addition to its core shipbuilding business, the company is diversifying into the biopharmaceutical sector, focusing on new drug development and the commercialization of pharmaceutical products.

Recent filings

Filing Released Lang Actions
[기재정정]주요사항보고서(감자결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) filed with the Korean Exchange regarding a capital reduction (감자 결정). It details a correction to a previously filed capital reduction notice, specifically updating the number of shares involved. Since this relates to a change in capital structure and share issuance/reduction, it falls under the 'Share Issue/Capital Change' category.
2022-07-14 Korean
단기차입금증가결정
Capital/Financing Update Classification · 100% confidence The document is a regulatory filing from Medicox regarding a decision to increase short-term borrowings. It details the amount, purpose (repayment of convertible bonds), and board approval status. This falls under financing activities and capital structure changes, which is best categorized as CAP (Capital/Financing Update).
2022-07-14 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership, specifically due to capital reduction (감자), and includes information on the reporting entity, shareholding ratios, and collateral agreements. This falls under the category of Major Shareholding Notification.
2022-07-13 Korean
주권매매거래정지해제(감자 주권 변경상장)
Delisting Announcement Classification · 100% confidence The document is a short regulatory notice regarding the lifting of a trading suspension for a specific company (Medicox) due to a capital reduction (reverse stock split) and subsequent relisting. It does not contain financial statements or detailed reports, but rather serves as a formal regulatory announcement from the exchange. As it does not fit into specific categories like M&A or dividends, it falls under the general regulatory filing category.
2022-07-12 Korean
[기재정정]주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) from a Korean company, Medicox, detailing a correction (정정신고) to a previously announced third-party capital increase (유상증자). It outlines changes to share counts, issuance prices, and payment dates following a capital reduction. This falls under the category of announcements regarding new share issues or capital structure changes.
2022-07-11 Korean
주요사항보고서(소송등의제기)
Legal Proceedings Report Classification · 100% confidence The document is a 'Major Report' (주요사항보고서) filed with the Korean financial authorities regarding the filing of a lawsuit (소송 등의 제기). Specifically, it details a request for an injunction against a new share issuance. Since the document pertains to legal proceedings and litigation involving the company, it falls under the 'Legal Proceedings Report' category.
2022-07-08 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.